Tue, May 20, 9:20 PM (54 days ago)
**NanoVibronix, Inc. (NAOV) Q1 2025 Financial Summary** **Financial Health and Performance:** - **Revenue:** $1,025,000 (up 11% YoY from $921,000). - **Gross Profit:** $369,000 (down 44% YoY from $664,000). - **Net Loss:** $2,495,000 (increased by 324% YoY from $588,000). - **Cash Flow:** Negative $1,343,000 from operations, offset by $1,050,000 from financing activities, leaving $601,000 in cash. **Key Metrics:** - **Gross Margin:** 36% (down from 72% YoY). - **Operating Expenses:** $2,221,000 (up 79% YoY from $1,232,000). - **R&D Expenses:** $530,000 (up 338% YoY from $121,000). - **Selling & Marketing:** $349,000 (up 112% YoY from $165,000). - **General & Administrative:** $1,342,000 (up 42% YoY from $946,000). **Quarterly Performance Discussion:** - **Revenue Growth:** Driven by the ENvue merger, contributing to overall growth. - **Profit Margins:** Decreased due to increased costs and lower wholesale sales prices. - **Cash Flow:** Negative operational cash flow, reliant on financing for liquidity. **Trends and Uncertainties:** - **Merger Impact:** ENvue merger significantly impacted financials. - **Stock Performance:** Reverse stock split and Nasdaq compliance efforts. - **Future Operations:** Dependence on additional capital raising and product commercialization. **Going Concern:** - **Liquidity:** Substantial doubt about continuing as a going concern due to insufficient resources for the next 12 months. - **Capital Needs:** Requires additional financing to sustain operations and achieve profitability. **Future Outlook:** - **Capital Requirements:** Dependent on equity financings and strategic alliances. - **Market Risks:** Subject to geopolitical conflicts, regulatory changes, and economic conditions. **Ticker:** NAOV